10.31.25 -- From Lab to Plant: Managing Operational Environment During Scale-Up

AI and MES can’t meet pharma’s visual inspection demands. Discover how purpose-built software ensures defect detection, compliance, and paperless quality for safer, more efficient operations.

Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.

Gain insights into the nuances of cleanroom conceptual design for GMP operations and learn how an integrated approach can ensure regulatory compliance, functionality, and environmental performance.

Explore how companies are streamlining validation with AI and CSA principles, as well as practical strategies that boost efficiency, accuracy, and compliance—backed by real-world examples.

Real-time viable particle monitoring instruments have been available for over a decade. Read in detail about this technology and how it is used to detect viable particles in real time.

See how modern manufacturing software is transforming operations with AI-driven insights to empower CDMOs and CMOs to boost efficiency, agility, and client satisfaction in a competitive landscape.

Discover a comprehensive guide comparing traditional manufacturing execution systems and operations platforms to help you choose the right solution for your business.

Pre-use, post-sterilization integrity testing ensures filters remain undamaged and effective during aseptic manufacturing. Find out how you can successfully perform PUPSIT with proven solutions.

Uncover how a validated Spinal Nerve Ligation (SNL) model enables effective preclinical evaluation of novel analgesics for neuropathic pain.

Delve into how medical device companies aim to balance patient safety with environmental stability by offering bio-based UHMWPE, which reduces carbon footprints by up to 70%.

Examine a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.

Learn how a top 20 US-based pharma company achieved more capacity to meet commercial supply needs in an accelerated timeline followed by pre-approval inspection with the help of a CMO partner.

Review actionable strategies that can lead to higher success rates and smarter resource investment, paving the way for a successful path to IND submissions and commercialization.